MarketsandMarkets is proud to announce the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 22nd -23rd, 2020.
While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.
Our aim for the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference is to unite all stakeholders in a virtual room during these remarkable times to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.
The virtual conference will also hold discussion on the impact due to COVID-19 in RWD space- Identifying and overcoming those challenges efficiently
From pharmaceutical and Biopharmaceutical companies-
Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologist, within the following departments